In the last few years, the use of enzyme labels in immunoassays has been investigated. The aim of this review is to evaluate critically the role of such labels in clinical biochemistry. Special attention has been given to the problems involved in preparing enzyme labels and the ways in which such labels can be used in a variety of heterogeneous and homogeneous assay systems. • Present address: Blend Mcludoe Centre. Queen Victoria Hospital, East Grinstead, Sussex RH 19 3D7. 1 Availability of purifierl low-cost homogeneous enzyme preparations 2 High specific activity 3 Presence of residues through which the enayme can be cross-linked to other molecules with minimal loss of both enzyme and antigen activity 4 Stable enzyme conjugates 5 Enzyme absent from biological fluids 6 Assay method that is simple. cheap. sensrnvc, precise, and no affected by factors present in biological Iluids 7 Enzyme, substrate. cofactors, etc, should not pose a potential health hazard.
lmrnunoassays are a group of protein binding assays in which the molecular recognition properties of antibodies are used. These assays usually make use of labelled antigen, hapten, or antibody. Radioisotopes are by far the most widely used labels (Yalow and Berson, 1959; Ekins, 1960) . The radioimmunoassay (RIA) method allows the quantitation of extremely small amounts of a wide variety of compounds present in complex biological systems (Skelley et al., 1973) . However, molecules labelled with gamma-emitting isotopes, such as iodine-125 have a relatively short shelf-life; health hazards may be involved in their preparation; radioactive and organic waste must be safely disposed of; and the equipment required to measure radioactivity is expensive.
One further requirement of RIA is a separation step. The binding of antibody to the antigen does not affect the activity of the label. In order to determine the proportion of labelled antigen bound by the antibody and the effect of unlabelled antigen upon this distribution it is necessary to separate free from bound antigen. This separation step increases the complexity of the assay and is a major obstacle in the automation of RIA. Several of the non-isotopic immunoassays require no separation step.
For these reasons, alternative labels have been investigated in an attempt to retain the advantages of specificity and sensitivity of immunoassays without using radiolabels. Non-isotopic labels used include bacteriophages (Haimovich et al., 1970) , erythrocytes (Alder and Chi-Tan, 1971 ), stable free radicals (Leute et al., 1972) , chemiluminescent labels (Schroeder et al., 1976) , fluorescent groups (Shaw et al., 1977; Ullman et al., 1976; Miller, 1979) and enzymes.
This review will cover the more recent advances in the field of enzyme immunoassay (EIA). Earlier work in this field has been reviewed by Scharpe et al. (1976) , Wisdom (1976) , and Schuurs and van Weemen (1977) .
Properties of enzyme-labels
Enzymes can function as labels as their catalytic properties allow the detection and quantitation of extremely small quantities of immune reactants. The advantages and disadvantages of using enzymelabels in immunoassay systems are listed in Table I . :l Reagents a re relatively cheap and Can have a long shelf-life.
:i A variety of enzvrnes can be used as labels; in consequence: (a) multiple simultaneous assays are possible; (b) labels may be prepared using a wide variety of conjugation techn iq ues ; (c) a number of systems fur detecting enzyme activity may be used. 4 Equipment can be inexpensive and is widely available. :i No radiation hazards uccur during labelling or disposal of wastes. (j Homogeneous assays are readily automated and can be rapid. Ideally, an enzyme label should possess the properties listed in Table 2 . In practice, few if any enzymes possess all these properties. The choice of enzyme employed should be dictated by the nature of the assay. For instance, in heterogeneous assays (assays which require a separation step) the enzyme activity is usually measured on the washed bound 222 M. J. O'Sullivan, J. W. Bridges and V. Marks The activity of enzyme labels has usually been measured by spectrometry. Fluorimetry has been used for~-galactosidase (Kato et al., 1975a) and glucoamylase (Ishikawa, 1973) ; turbidity measurements for lysozyme (Rubenstein et al., 1972) and scintillation counting for acetylcholinesterase (van der Waart and Schuurs, 1976 ).
An interesting innovation is thermometric enzyme immunoadsorbent assay (TELlSA), in which enzyme activity is measured by the heat produced during the enzyme catalysed reaction . The basis of this method is that a thermistor is inserted into a column containing antibody bound to a solid phase. A sample containing enzymelabelled antigen and free antigen is passed through the column followed by a pulse of substrate. The heat produced during the substrate pulse is inversely proportional to the concentration of free antigen in the sample. The column is regenerated by acid treatment and reused. The entire cycle is completed in 12 minutes, with a reported capacity of approximately 25 samples a day. The assay is sensitive to approximately 10 ng/rnl of gentamicin and has good precision with an interassay coefficient of variation of 5·1 % or less. The results obtained using this method correlated well with gentamicin levels determined by microbiological techniques.
The same group have also used electrodes to measure enzyme activity in a similar system (Mattiasson and Nilsonn, 1977) . The sensitivity of the electrode system was reported to be less than that of the thermistor system which has been reported to be sensitive to 1O-13M human serum albumin .
The authors also report a modification of the above method using antigen-specific antibodies reversibly immobilised on the solid support using anti-IgG antibodies. This method is reported to give high operational stability of the analytical system .
Recently, chemiluminescence has been used in EIA. The chemiluminescence results from the oxidation of pyrogallol by peroxidase-labelled antigen. In a competitive EIA using solid phase antibody, I ng of staphylococcal enterotoxin B could be detected (Velan and Halmann, 1978) . Assays for cortisol, insulin, thyroid stimulating hormone (TSH) and neocarzinostatin have also been developed using peroxidase labels. Peroxidase activity was measured spectrophotometrically, fluorophotometrically, or by chemiluminescence. The chemiluminescence generating reaction was the oxidation of luminal by H202 using peroxidase as catalyst. The spectrophotometric assay was sensitive to 100 pg of cortisol, the fluorophotometric method to 25 pg, and the chemiluminescence method to 10 pg. The chemiluminescence method could not be applied phase. Endogenous enzyme and factors interfering with enzyme activity may be removed by this washing procedure so the absence of these factors from serum is not an absolute requirement in this type of assay. However, homogeneous assays (assays that do not require a separation step) will be more susceptible to this type of interference, so it is very desirable to use an enzyme absent from, and unaffected by, factors present in biological samples. The sensitivity required of an assay also affects the choice of enzyme. Lysozyme has been used as a label to detect a number of drugs present in urine in the mg/litre range (Rubenstein et al., 1972; Schneider et al., 1973) . Owing to the low specific activity of this enzyme, it would not, however, be suitable for assays which require more sensitivity.
The enzymes that have been used as labels in EIA are listed in Table 3 . Horseradish peroxidase, -galactosidase, and alkaline phosphatase are the to TSH, insulin, or neocarzinostatin because of the presence of interfering factors in plasma (Tsuji et al., 1978) .
Owing to the potential sensitivity of the detection system the measurement of enzyme-labels by luminescence reactions may well be a growth area in EIA. Luciferase may find an application as such a label.
In summary, there are a number of methods available for measuring the enzyme activity of enzyme labels. Spectrometry is the simplest and most widely used method. Fluorimetry may be used for assays that require extreme sensitivity. A number of interesting methods of measuring enzyme activity have recently been introduced but it is too early to evaluate the general applicability of these systems.
Preparation of enzyme-labels
The object of preparing enzyme conjugates is to provide a label that is capable of measuring accurately the desired compound over the clinically significant concentration range. The functional residues available and the stability of both the enzyme and the second molecule to be coupled determine the crosslinking chemistry that can be employed. Numerous methods have been used to prepare protein-protein (Kennedy et 01., 1976) and protein-hapten conjugates (Erlanger, 1973 ).
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Only the methods that have proved particularly valuable in preparing labels for EIA will be discussed.
Protein-enzyme conjugates
The major problem in linking an enzyme to a second protein is the fact that enzymes are proteins. Most conjugation methods are as likely to produce enzyme-enzyme and protein-second protein conjugates as the desired enzyme-second protein conjugate. In addition, the extent of cross-linking is often difficult to control, resulting in polymerised products which are unlikely to provide suitable labels for sensitive EIAs. The preparation of enzymeantibody conjugates has the advantage that the same method can be used to conjugate antibodies raised against different antigens or haptens. Furthermore, it is possible to devise ways in which one enzymeantibody label can be used to determine a number of different antigens and haptens .
I THE ONE-STEP GLUTARALDEHYDE METHOD
This is one of the most widely used procedures. The dialdehyde, glutaraldehyde, can link proteins through their amino-residues (Avrameas, 1969) to form a Schiff's base (Fig. 1) . This is followed by further reactions, the details of which are slowly Protein --NIh being unravelled (Whipple and Ruta, 1974) . The conjugates are prepared by simply mixing the enzyme and second protein in the presence of glutaraldehyde. The two most widely studied conjugates, IgG-alkaline phosphatase and IgG-horseradish peroxidase, have been characterised as being electrophoretically heterogeneous and large enough to be eluted in the void volume of a Sephadex G200 column (Avrameas, 1969) . Extensive self-linkage and loss of IgG activity usually occurs (Boorsma and Kalsbeek, 1975) . Furthermore, in the case of horseradish peroxidase, only about 5~~may be conjugated (Clyne et al., 1973) . A comparison has been made of the alkaline phosphatase and lactoperoxidase-antibody conjugates prepared using glutaraldehyde (Ford et al., 1978) . The efficiency of coupling alkaline phosphatase to IgG was 0·44 % and that of lactoperoxidase 49 %. The IgG and lactoperoxidase polymerised as globular aggregates, while alkaline phosphatase polymerised as extended chains. The reason for the differences in behaviour between the two enzymes is not understood.
A comparative study of the ability of a number of enzyme-antibody conjugates prepared using this method to detect specific antibodies indicated that the sensitivity was in the order alkaline phosphatase > glucose oxidase > peroxidase (Guesdon and Avrameas, 1977) . However, the sensitivity of the detection of peroxidase and glucose oxidase activity was adversely affected by the binding of the chromagen to the solid phase used in the assay; thus this result may not apply to other substrates. The activity of each label was measured by spectrometry.
THE TWO-STEP GLUTARALDEHYDE METHOD
This method has been limited to horseradish peroxidase. This enzyme is unreactive towards glutaraldehyde, probably as a result of the blockage of the majority of its amino groups by alkyl isocyanate, which occurs in horseradishes (Nakane et al., 1966) . In consequence, the enzyme is activated, but not extensively self-polymerised, by reaction with glutaraldehyde. After removal of excess glutaraldehyde by gel filtration, the activated enzyme is reacted with antigens or antibodies containing amino residues (Avrameas and Ternynck, 1971) . The reaction scheme is illustrated in Figure 1 . The incorporation of enzyme into the conjugate is not large, but mostly low molecular weight conjugates are obtained (Avrameas and Ternynck, 1971) .
Antibody-horseradish peroxidase conjugates prepared by the two-step procedure tend to yield an assay with sensitivity superior to that using conjugates prepared by the one-step method (Van Weemen and Schuurs, 1974) .
THE PERIODATE METHOD
This procedure has been used mainly to couple horseradish peroxidase to other proteins (Nakane and Kawaoi, 1974) . The reaction involves: (a) blockage of the amino residues of the enzyme by reaction with f1uorodinitrobenzene; (b) oxidation by periodate of the carbohydrate residues of the enzyme to produce aldehyde groups; (e) reaction between these aldehydes and free amino residues on the second protein; (d) stabilisation of the crosslink by reduction with sodium borohydride (Fig. 2 ). Self-coupling of the enzyme is prevented by the prior blocking of the amino-groups. Up to 70% of the enzyme and 99 % of the IgG have been reported to be conjugated (Nakane and Kawoi, 1974) . In contrast, Sparacio et al. (1975) report incorporation of 15% of the enzyme and 18% of the antibody. This method appears to be an improvement on the glutaraldehyde method but is limited in its application to glycoprotein enzymes.
/NH
The periodate oxidation method proved superior to the glutaraldehyde and carbodiimide methods in preparing human placental lactogen-peroxidase conjugates (Williams, 1978) . Peroxidase-insulin conjugates prepared using the periodate method proved superior to catalase-insulin conjugates prepared using the glutaraldehyde method because of the low yield with the glutaraldehyde method . antibodies were coupled to [J-galactosidase, which contains free sulphydryl residues ( Fig. 4) . Self-
Non-covalent coupling
A non-covalent peroxidase-second antibody label has been reported (Yorde et al., 1976) . This label comprised a rabbit anti peroxidase/horseradish peroxidase non-covalent complex which was bound by anti-rabbit IgG to form an anti-rabbit IgGhorseradish peroxidase label. This label has been used to measure human chorionic gonadotrophin in a competitive enzyme-linked immunoassay (CELIA).
polymerisation of the antibodies was not possible because of the heterobifunctional nature of MBS and the lack of free sulphydryl residues in antibodies. Approximately 80/~of the enzyme was conjugated to immunologically active antibody with )0 %retention of both enzyme and antibody activity.
The MBS method was simpler to perform and gave higher yields of the incorporated enzyme than the phenylenedimaleimide method (O'Sullivan et al., in preparation) . The M BS method is potentially applicable to any enzyme containing sulphydryl residues; if necessary, these residues may be readily introduced into non-sulphydryl containing enzymes (Taut et al., 1973) .
The preparation of N-hydroxysuccinimide esters of N-(4-carboxycyclohexylmethyl)-maleimide and N-(4-carboxyphenylmethyl)-maleimide has been reported. The reagents may be used to introduce maleimide residues into a wide variety of compounds for conjugation to molecules containing sulphydryl residues. The reagents are more stable than existing compounds used for this purpose . approximately 50% and 90~~of the enzyme was coupled to IgG and Fab' respectively. This reagent has also been used to couple [Jgalactosidase to donkey anti-sheep Fe, donkey antirabbit Fe, and donkey anti-guinea pig IgG . Sulphydryl residues were introduced into the antibodies by reaction with rnercaptobutyrimidate. During this reaction the antigen binding sites were protected by adsorbing the antibodies onto an immunoadsorbent. Approximately 50 % of the enzyme was conjugated to immunologically active antibody without loss of enzyme activity.
m-Maleimidobenzoyl-N-hydroxysuccinimide (MBS)
This reagent has been used to couple insulin (Kitagawa and Aikawa, 1976) and donkey anti-sheep Fe to [J-galactosidase. MBS is a heterobifunctional reagent containing both a hydroxysuccinimide ester and a maleimide residue. Maleimide residues were introduced into the antibody by reaction between the hydroxysuccinimide ester portion of MBS and amino residues in the antibody. After removal of excess MBS the activated 4 N,N'-O-PHENYLENEDIMALEIMIDE Molecules containing sulphydryl residues react rapidly and selectively under mild conditions with maleimides. The bifunctional reagent N,N'-o-phenylenedirnaleimide, has been used to crosslink [Jgalactosidase to insulin (Kato et al., 1975a) , rabbit IgG , and rabbit Fab' fragment (Kato et al., 1975b) . Sulphydryl residues were introduced into these proteins by mercaptosuccinylation or by reduction of existing disulphide bridges. The modified proteins were then reacted with maleimide and, after removal of excess maleirnide, coupled to [J-galactosidase ( Fig. 3 ). No enzyme activity was lost during the conjugation process, and 
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Hapten-enzyme conjugates
Many of the cross-linking methods used to prepare enzyme-hapten labels are similar to those used to prepare hapten-protein immunogens. Because of the wide diversity in the structure of haptens numerous cross-linking methods have been employed. The mixed anhydride reaction (Erlanger et ai., 1959) is the most popular at present, but the cross-linking procedures used are certainly not ideal; better crosslinking reagents, especially more heterobifunctional ones similar to MBS (Kitagawa and Aikawa, 1976) , are needed. For optimal enzyme labels it is generally considered advisable to: 1 Avoid linking the enzyme to important antigenic sites on the hapten. If these sites are bound there may be a reduction of the avidity of the antibody for the label with consequent loss in sensitivity and specificity of the assay (Van Weemen and Schuurs, 1975) . 2 Use a different site and crosslinking method in preparing the label from that used to prepare the immunogen. Antibodies produced against immunogens may recognise the bridge between the hapten and carrier molecule in addition to the hapten. If the same bridge is present in the label the antibody may bind the label more avidly than the free hapten, resulting in an insensitive assay (Van Weemen and Schuurs, 1975) . However, this does not always prove to be the case (Dray et al., 1975) .
The degree of substitution of hapten into the enzyme is an area that requires further investigation. To obtain >90% binding of l3-galactosidase by excess antibody, incorporation of an average of 10 cortisol molecules per l3-galactosidase molecule was required (Comoglio and Celada, 1976) . This is in agreement with our results for triiodothyronine (T3)-I3-galactosidase labels . Whether this level of incorporation is required because the hapten is damaged during the crosslinking process or because it becomes buried in the interior of the enzyme is not known. The T3 assay was approximately 50% as sensitive as a T3 RIA using the same antisera and a similar protocol . A sensitive assay for oestradiol-1713 has been reported in which an average of only 1'7 steroid molecules were coupled per 13galactosidase molecule (Exley and Abuknesha, 1978) . At present the best approach is to prepare labels with varying degrees of hapten incorporation and to use that label which provides the most satisfactory standard curve for the assay in question.
Removal of uncoupled immune reactant from the label is obviously advantageous and can generally be accomplished by gel filtration. Removal of nonconjugated enzyme from a hapten-enzyme conjugate 227 is difficult. Although affinity chromatography has been employed (Exley and Abuknesha, 1977) most workers attempt to maximise the incorporation of enzyme into the conjugate so minimal free enzyme remains.
Conjugation methods

MIXED ANHYDRIDE
The mixed anhydride method has been used to couple many haptens including oestradiol (Van Weemen and Schuurs, 1972; Numazawa et al., 1977) , progesterone , and methotrexate to enzymes. The mechanism of the reaction is illustrated in Figure 5 .
CARBODIIMIDE METHOD
Water-soluble carbodiimides have been used to couple testosterone (Tateishi et al., 1976) and cortisol to enzymes.
Both the carbodiimide and mixed anhydride methods produce a peptide bond between a carboxylic acid residue on the hapten and an amino group on the enzyme. Carboxylic acids may be introduced into haptens containing hydroxyl groups by reaction with succinic anhydride (Erlanger et al., 1959) . Ketones and aldehydes can be used as determinant groups after reaction with carboxymethyloxime to form O-(carboxymethyl) oximes containing carboxylic acid residues which may be modified as described above (Erlanger et al., 1959) .
A cortisol derivative, cortisol 21-amine, has been conjugated to alkaline phosphatase using the carbodiimide method (Kobayashi et al., 1978) . This carboxylic acid rich enzyme was first reacted with the carbodiimide, followed by condensation with the amine residue of the cortisol derivative.
BIFUNCTIONAL IMIDATES
Haptens containing amino residues may be coupled to enzymes using bifunctional imidates such as dimethyladipimidate (Fig. 5) . The hapten and crosslinking reagent are allowed to react in an anhydrous medium and are then transferred to an aqueous enzyme solution. The method has been applied to T3 and desmethylnortriptyline, a derivative of nortriptyline (AI-Bassam et al., 1978a) . MBS This reagent has been used to couple haptens containing amino groups to l3-galactosidase which contains sulphydryl residues and has been applied to viomycin and insulin (Kitagawa and Aikawa, 1976) . A similar reagent, N-(3-maleimidopropionyl glycoxy) succinimide (MPGS), has been used to couple a-galactosidase to ampicillin (Kitagawa et 01., 1978b) , viomycin, and gentamicin (Kitagawa et 01., 1978c) .
Types ofEIA EIA can be subdivided into two major types, heterogeneous and homogeneous assays. In heterogeneous assays the antigen-antibody interaction does not affect the activity of the label. To determine the effect of standard or sample upon this equilibrium, the bound label must be separated from the free label. In homogeneous EIAs the antigen-antibody interaction affects in some way the activity of the label, and assays have been devised in which this modification of enzyme activity is determined without the need for a prior separation step.
The principles behind heterogeneous EIAs are the same as those for RIA except that enzyme activity rather than radioactivity is measured. EIAs analogous to competitive radioimmunoassay (Yalow and Berson, 1959) , immunoradiometric assay (Miles and Hales 1968) , two-site immunoradiometric assay (Woodhead et 01., 1974,) and the double antibody immunoradiometric assay (Woodhead et 01., 1974) have all been described.
HETEROGENEOUS ASSAYS
Competitive EIA for antigen (or hapten)
This method is analogous to classical RIA. It involves competition between labelled and unlabelled antigen for a limited amount of antigen-specific antibody. The amount of enzyme-labelled antigen bound by the antibody is inversely proportional to the concentration of unlabelled antigen present (AI-Bass am et 01., 1978a).
lmmunoenzymometric assay
Enzyme-labelled antibody is reacted with antigen, and excess solid phase antigen is then added. The enzyme activity bound to the solid phase is inversely proportional to the concentration of free antigen (Maiolini et al., 1975) .
3 Two-site immunoenzymometric assay Solid phase antibody is incubated with the antigen to be measured and washed, and enzyme-labelled antibody is added. Enzyme activity bound to the solid phase is proportional to the concentration of antigen present. This method can be used only for antigens able to bind at least two antibodies (Clark and Adams, 1977) M. J. 0 'Sullivan, J. W. Bridges and V. Marks 4 Sandwich assay for antibody detection Solid phase antigen is incubated with a sample containing the antibody to be detected. The solid phase is then washed, and enzyme-labelled second antibody is added. The second antibody is raised against immunoglobulins of the animal species in which the first antibody was raised. The amount of enzyme activity bound to the solid phase is proportional to the amount of antigen-specific antibody present (Engval and Perlmann, 1972) .
Double-antibody immunoenzymometric assay for antigen determination
This method is derived from method 4; free antigen prevents antigen-specific antibody binding to the solid phase. Thus the amount of enzyme second antibody bound to the solid phase is inversely proportional to the quantity offree antigen in the sample . This method has the advantage that one label can measure many antigens.
A comparison of three heterogeneous assay procedures for the enzyme-linked quantitative determination of guinea-pig anti-insulin antibody has been published Separation methods The choice of separation phase is limited in EIA by the large size of the enzyme label. This precludes the use of methods such as charcoal separation, which are based on differences in molecular weight between the bound and unbound label. Suitable methods include the use of double antibody (Miyai et al., 1976) and antigens or antibodies attached to some type of solid support (Engvall and Perl mann, 1971 ). An ingenious separation system has been described which utilises magnetic polyacrylamideagarose beads (Guesdon and Avrameas, 1977) . Advances in instrumentation include a colorimeter for the direct measurements of microplates in EIA systems (Clem and Yolken, 1978) and the introduction of automation .
HOMOGENEOUS ASSAYS
I Enzyme-labelled hapten The 'EMIT' (©, Syva, Maidenhead, UK) assay is the most widely used homogeneous system. The principle of the assay is illustrated in Figure 6 . Conjugation of the enzyme to the hapten does not destroy the enzyme activity. However, binding of hapten-specific antibody to the label results in inhibition of enzyme activity. Free hapten in the standards or samples relieves this inhibition by competing for antibody. Thus, in the presence of antibody, the enzyme activity is proportional to the concentration of free hapten (Rubenstein et al., Fig.6 Principle of the EMIT homogeneous assay system. Schneider et al., 1973) . Antibody is believed to inhibit the enzyme by inducing or preventing conformational changes necessary for enzyme activity (Rowley et al., 1975) .
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An exception to this mechanism is the thyroxine assay. In this instance the thyroxine-malate dehydrogenase conjugate is enzymatically inactive but is activated when bound by thyroxine antibodies . It is believed that the conjugated thyroxine inhibits the enzyme by binding to the active site, so increasing the 'apparent' K m of the substrate. The antibody reactivates the enzyme by pulling the thyroxine out from the active site.
Lysozyme (Rubenstein et al., 1972) , the first enzyme used in this type of assay, has a number of disadvantages. Endogenous enzyme may be present in urine, the enzyme activity is affected by changes in urine pH which occur on prolonged storage, and the enzyme has a slow turnover rate. More recently, malate dehydrogenase (Rodgers et al., 1978) and glucose 6-phosphate dehydrogenase (Chang et al., 1975) , which are less likely to be affected by serum factors and have a higher turnover rate, have been used. Although the EMIT assay is generally used to measure drugs in the mg/Iitre range the digoxin assay has a sensitivity of 1~g/litre (Chang et al., 1975) .
Phenytoin and phenobarbital serum levels were measured by gas-liquid chromatography (GLC), high performance liquid chromatography (HPLC), and the EMIT method. Good agreement between the three methods was shown. However, a proportional error was found for phenobarbital, E]A yielding significantly lower results than the chromatographic methods. The authors report that the error introduced was not sufficient to affect the clinical significance of the result (Kumps et al., 1978) . The precision of the three methods was comparable. The sensitivity of the EM]T assay was slightly less than that of the other methods. The authors, in a comparison of the three methods, state that the advantages of the EMIT method were its rapidity (3 minutes), the potential for automation, and the low sample volume required (advantageous for monitoring epileptic children). The disadvantages were that the method did not allow simultaneous analysis of several drugs, the limited concentration ranges for accurate determinations, interference by some serum components (icteric, lipaemic, or haemolysed sera), and the cost of the apparatus and reagents. The authors conclude that GLC and HPLC are the methods of choice for research work; for routine purposes, E1A may be more suitable (Kumps et al., 1978) .
To date the EMIT method has been used only to measure haptens. A review on the applications of the EMIT method has been published (Scharpe et al., 1976) . A method for increasing the sensitivity of the EMIT assay has been devised (Lasky et al., 1978) , and automated computer analysis methods have been published (Rodbard and MacClean, 1977) .
2 Substrate-labelled hapten A novel homogeneous assay system based on substrate-labelled hapten has recently been described (Burd et al., 1977b) . The principle of the assay is illustrated (Fig. 7) . A derivative of umbelliferone-13-galactoside was covalently coupled to gentamicin. The drug/dye conjugate was a substrate for 13galactosidase and yielded a fluorescent product. However, when the conjugate was bound by antigentamicin antibody it was inactive as a 13-galatosidase substrate. This inhibition was relieved by free gentamicin. Thus the rate of production of fluoressence was proportional to the concentration of free gentamicin present in samples or standards.
An earlier paper described an ester-linked system, which had a number of defects (Burd et al., 1977a) . Human serum contains high esterase activity which would interfere with any assay based on esterase activity. In addition, the ester link was not completely stable under the assay conditions, resulting in a high background fluorescence. These defects were overcome by using the 13-galactoside-linked system. An immunoassay for tobramycin has been developed. The assay uses a single-point measurement of fluorescence, which is simpler than the rate assay previously described (Burd et al., 1978) . This method has the disadvantage that the amplification property of the enzyme is not used, which limits the potential sensitivity of the system. This has been partially overcome by using a sensitive fluorimetric method to determine product formation.
Co/actor-labelled ligands
Cofactor-labelled ligands have been used in an homogeneous EIA . The ligands, biotin and 2,4-dinitrobenzene, were coupled to a derivative of NAD to provide cofactor conjugates which were active with several dehydrogenases. The conjugates were cycled in reactions employing lactic dehydrogenase and diaphorase, as illustrated in Figure 8 . Cycling rates were measured by the spectrophotometric determination of reduced thiazolyl blue. The cycling of the biotin conjugate was inhibited by aviden and that of the 2,4-dinitrophenyl conjugate by specific antibodies. This inhibition was reversed by free biotin and 2,4-dinitrophenyl-6amino-eaproate in their respective systems.
A co-enzyme cycling reaction for oestriol measure- ment has been reported. An oestriol-NAD conjugate was cycled using malic and alcohol dehydrogenases. Malate, one of the products of the cycling reaction, was determined with malic enzyme and NADP+, and the amount of NADPH formed was measured f1uorimetrically. Cycling was inhibited by anti-oestriol IgG. Compared with the lactic dehydrogenase-diaphorase enzymic coupling system for NAD-Iabelled ligands, the present system gave a lO-fold higher cycling rate. The sensitivity obtained (2 nM) was sufficient to measure oestriol from plasma samples (Kohen et aI., 1978) . This method may be subject to interference by endogenous cofactors and degrading enzymes found in biological materials (Schroeder et al., 1976) . If these problems can be overcome then this type of assay may be a useful addition to immunoassay methods.
Enzyme-labelled antibodies
Phospholipase C has been conjugated to rabbit anti-human IgG. The enzyme activity of the conjugate was inhibited by human IgG but not by rabbit or goat IgG. The substrates used for the enzyme were phospholipids, which formed part of the membrane of erythrocytes. Wei and Riebe (1977) postulated that the human IgG sterically prevents access of the enzyme label to its substrate which they viewed as being immobilised in the membrane and therefore less accessible to the catalytic site of the enzyme. Appropriate attachment of substrate to solid matrices may similarly be effective for inhibiting the enzyme activity of labelled antibody. Large molecular weight antigens are more likely to yield homogeneous assays in this system.
Applications of EIA
In principle, EIA can be applied to all antigen (hapten)-antibody systems. EIAs have been de-veloped for serum proteins, hormones, drugs, and a wide variety of other antigens and antibodies directed against them. Extensive lists of compounds for which EIAs have been developed have been published (Schuurs and Van Weemen, 1977; Wisdom, 1976) . More recent methods for antigens, haptens, and antibodies by both heterogeneous and homogeneous systems are illustrated in Tables 4 to 6 .
Precision, bias, and accuracy of EIA An assay result may be incorrect because of either random or systematic errors associated with a Table 4 Applications of EIA 231 particular method. The accuracy of EIAs will be affected by the same factors that affect RIA. However, additional factors may influence EIA systems. The measurement of enzyme activity requires the addition of substrate and usually a timed addition of reagent to terminate the reaction. These steps can potentially decrease the precision of the assay. The separation step can be a source of imprecision in RIA but not in homogeneous EIAs. The precision of a number of EIA has been tabulated (Schuurs and Van Weemen, 1977) , and it is apparent that it can be of the same order of magnitude as that of RIA. One further potential problem with EIA is that compounds present in samples may affect the enzyme activity, so introducing inaccuracy into the determinations. These effects may be minimised by diluting the sample or by performing the assay on the washed bound phase.
One method of assessing the accuracy of a method is to compare the results with those obtained using an established method, preferably GLCjmass spectrometry. Comparisons of EIA results have been made with those obtained by other methods, including RIA (Finley and Williams, 1978; Drost et al., 1977) , spectrometry , Schmitz ,I al. (1977) Grippenberg e al, lynn and Lsson (1978) Furshy er al. (1971l) Yolken ,I at. (1977) Halle ,I al. (1977) Herrman cI at. (1977) Scherrer and Bernard (1977) Ellens and de Leeuw (1977) Scherrer and Bernard (1977) Cleary ,I al. (1978) Pruvot and Sippel ,I al. ( ) Deelder ,I al. (1977 Theakston ,I al, (1977) Van Knappen and Panggabean (1977) Wall. " al. (1977) Ruttenberg and Buys (1977) Whittle e al. (1977) Mcllors and Mellor's (1978) • EMIT is a registered trademark of Svoa, Maidenhead , UK Homogeneous assays: I. The "EMIT'· method Sensitivity Table 6 Applications of EIA Future of EIA be that of 0·03 fmol/tube of ornithine-aminotransferase using l3-galactosidase as label and a f1uorimetric detection system .
The sensitivity of EIAs for steroid hormones was found to be largely influenced by the procedure used to separate antibody-bound and free steroid. Solidphase systems using Sepharose-coupled antisera lacked sensitivity. Systems based on antisera coupled to microcrystalline cellulose and those involving precipitation with a second antibody had sensitivities similar to RIA (Joyce et al., 1978) . Similar results were reported by Tsuji and co-workers (1978) . Reducing the molar incorporation of steroid into the enzyme label improved assay sensitivity (Joyce et al., 1978) .
The sensitivity and reproducibility of EIAs for protein hormones were lower than those of RIAs. The specificity and sensitivity of steroid EIAs were highly influenced by the combination of antiserum and steroid conjugate used. Combinations in which the same steroid derivative was used for the preparation of immunogen and label (homologous systems) were, in general, more specific but less sensitive than heterologous systems. Using suitable antiserum and steroid conjugates, it was possible to obtain specificity, sensitivity, and reproducibility comparable with that of the correspondings RIAs (Bosch et al., 1978) .
EIA methods require improvement in a number of areas: I Improved heterobifunctional reagents for the synthesis of enzyme labels. 2 A systematic investigation of the influence of the degree of labelling, the site of crosslinking, and the nature of the bridge on the performance of enzymelabels. 3 A better understanding of the effects of biological samples on the activity of enzyme-labels. Strict comparisons of the merits of different enzymes, substrates, and detection systems. 4 Sensitive homogeneous assays able to measure large molecular weight antigens.
EIA is likely, at least in the foreseeable future, to be used: 1 for homogeneous assays of low molecular weight compounds present in biological samples at relatively high concentrations; 2 for qualitative and semiquantitative assays to screen for antigens derived from microorganisms and antibodies directed towards them; 3 as an alternative to RIA methods using tritium labels; 4 in those laboratories needing to perform a limited Finley and Williams (1978) Galen and Forman (1977) Gushaw and Miller (1978) (Booker and Darcey, 1975; Sun and Szafir, 1977) . Generally, published results have shown good agreement with other methods.
In conclusion, the accuracy of EIA results may potentially be affected by a number of factors not encountered in RIA systems. In practice, the precision of many EIAs appears to be comparable to that of other immunoassay systems, and the results obtained seem, in most instances, to correlate reasonably well with those obtained from RIA and other systems. However, the situation will be completely clarified only when EIAs are used routinely and the results analysed by quality control schemes, as is the case with a number of RIAs (Ratcliffe et al., 1978) .
Comparisons between the sensitivmes of different assays are difficult to make. The sensitivity of an assay is affected by the nature of the antiserum, the assay design, and the definition of sensitivity used. Many of the earlier EIAs were less sensitive than comparable RIA methods. Recently, EIA methods with a sensitivity comparable to that of RIA have been described for a number of compounds (Kitagawa and Aikawa, 1976; Kato et al., 1975a; AI-Bassam et al., 1978a; Exley and Abuknesha, 1978) . The most sensitive EIA so far reported appears ot number of tests but lacking facilities for counting radioisotopes; 5 in those countries where the political climate IS against the use of radiolabels; and 6 labels for use in immunohistochemistry.
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